Opzelura Ruxolitinib Cream For Vitiligo In Pakistan

Opzelura (ruxolitinib) Cream 1.5% is a topical prescription medicine containing ruxolitinib, a Janus kinase (JAK) inhibitor. It is indicated for the topical treatment of nonsegmental vitiligo in adults and pediatric patients 12 years and older.crownmart.pk

Key Features

• Contains ruxolitinib 1.5%
• Topical cream formulation
• Prescription medicine
• Indicated for nonsegmental vitiligo
• Approved for eligible adults and children aged 12+
• Supplied in 60 g and 100 g tubes according to the U.S. prescribing information

How Opzelura Ruxolitinib Cream For Vitiligo Works:

Vitiligo Is Thought To Be An Autoimmune Condition In Which The Body’s Immune System Mistakenly Attacks Melanocytes (The Pigment?producing Cells). Opzelura Works By Blocking Jak1 And Jak2 Enzymes — Key Parts Of The Immune Signaling Pathway — Thereby Reducing The Immune Attack On Melanocytes And Helping The Skin Gradually Re?establish Pigment In Affected Areas.

How Opzelura Is Used for Vitiligo

The current prescribing information recommends applying a thin layer twice daily to affected areas covering up to 10% of body surface area. Treatment should be used according to a healthcare professional’s instructions.

Important Safety Information

Opzelura is for topical skin use only and should not be used in the eyes, mouth, or vagina. The prescribing information contains important warnings concerning serious infections, malignancy, major cardiovascular events, thrombosis and blood-count abnormalities.

Because Opzelura is a prescription medicine, consult a qualified healthcare professional before starting or changing treatment.